Blair William & Co. IL Has $334,000 Holdings in Haleon plc (NYSE:HLN)

Blair William & Co. IL increased its stake in shares of Haleon plc (NYSE:HLN) by 21.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,449 shares of the company’s stock after purchasing an additional 7,020 shares during the period. Blair William & Co. IL’s holdings in Haleon were worth $334,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HLN. Cultivar Capital Inc. acquired a new position in Haleon in the second quarter valued at about $40,000. Allspring Global Investments Holdings LLC acquired a new position in shares of Haleon during the first quarter worth about $43,000. GAMMA Investing LLC boosted its position in shares of Haleon by 151.3% during the first quarter. GAMMA Investing LLC now owns 6,106 shares of the company’s stock worth $52,000 after buying an additional 3,676 shares during the period. Pinnacle Bancorp Inc. boosted its position in shares of Haleon by 29.8% during the first quarter. Pinnacle Bancorp Inc. now owns 6,188 shares of the company’s stock worth $53,000 after buying an additional 1,421 shares during the period. Finally, Hexagon Capital Partners LLC boosted its position in shares of Haleon by 66.6% during the second quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock worth $55,000 after buying an additional 2,677 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently weighed in on HLN shares. The Goldman Sachs Group cut Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. Morgan Stanley upped their price objective on Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research report on Friday, September 20th. Finally, Berenberg Bank assumed coverage on Haleon in a research report on Tuesday, August 6th. They set a “buy” rating for the company. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Price Performance

Haleon stock opened at $10.59 on Friday. Haleon plc has a 12 month low of $7.70 and a 12 month high of $10.76. The stock’s 50 day moving average is $9.91 and its 200-day moving average is $8.93. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $48.29 billion, a price-to-earnings ratio of 35.30, a PEG ratio of 3.12 and a beta of 0.26.

Haleon (NYSE:HLN) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). The company had revenue of $3.50 billion for the quarter, compared to analyst estimates of $3.55 billion. Haleon had a return on equity of 13.15% and a net margin of 9.71%. During the same period in the prior year, the company earned $0.08 EPS. Equities research analysts expect that Haleon plc will post 0.47 EPS for the current year.

Haleon Cuts Dividend

The firm also recently announced a semi-annual dividend, which was paid on Thursday, September 19th. Shareholders of record on Friday, August 16th were issued a $0.0514 dividend. This represents a dividend yield of 1.6%. The ex-dividend date was Friday, August 16th. Haleon’s dividend payout ratio is presently 36.67%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.